STOCK TITAN

National Health Investors - NHI STOCK NEWS

Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust (REIT) established in 1991, specializing in sale-leasebacks, joint ventures, and both mortgage and mezzanine financing. The company's primary focus is on need-driven and discretionary senior housing and medical investments.

NHI's diverse portfolio comprises various types of facilities including independent living, assisted living, and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings, and specialty hospitals. The company operates through two main segments: Real Estate Investments and the Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment includes investments in real estate leases, mortgages, and other notes receivables related to independent living, assisted living, and skilled nursing facilities among others. The SHOP segment involves ventures that own and operate independent living facilities, realizing revenue from rental, mortgage interest income, and resident fees and services.

Financially, NHI has demonstrated resilience and growth. As of the end of 2023, NHI maintained a robust balance sheet with $1.1 billion in net debt and leverage at just 4.4 times net debt-to-adjusted EBITDA. This strong financial profile is enhanced by investment-grade credit ratings from Moody's, S&P Global, and Fitch Ratings. NHI's financial health was further highlighted by the company exceeding its 2023 guidance for NAREIT FFO, NFFO, and FAD.

Recent achievements include a successful fourth quarter in 2023 with over $2.0 million in deferral repayments, no unexpected rent concessions, and substantial growth in the SHOP segment. The company has continued this momentum into 2024, generating notable revenue growth and maintaining high occupancy rates across its facilities. Looking ahead, NHI has a pipeline exceeding $300 million, with a significant portion already under letters of intent, ensuring ongoing investment and growth opportunities.

In February 2024, NHI announced a new stock repurchase plan totaling $160 million, reflecting its commitment to returning value to shareholders. The company also maintains a substantial revolving credit facility, offering significant liquidity for future investments and operational needs.

Partnerships and Programs:

  • Strategic partnerships with senior housing operators.
  • Joint ventures for operational and financial synergy.
  • Investment in high-yield real estate opportunities.

NHI’s commitment to long-term growth and stable financial health, combined with its strategic investment in senior housing and medical facilities, positions it as a vital player in the healthcare real estate market.

For more information, visit www.nhireit.com.

Rhea-AI Summary

National Health Investors (NYSE:NHI) announced its Q2 2024 results, showing improved performance compared to the previous year. Key highlights include:

- Net income per diluted share: $0.81 (Q2 2024) vs $0.92 (Q2 2023)

- NAREIT FFO per diluted share: $1.18 (Q2 2024) vs $1.05 (Q2 2023)

- Normalized FFO per diluted share: $1.18 (Q2 2024) vs $1.06 (Q2 2023)

- Normalized FAD: $51.8 million (Q2 2024) vs $44.6 million (Q2 2023)

NHI updated its 2024 guidance, raising NAREIT FFO, Normalized FFO, and Normalized FAD ranges. The company reported increased rental income, higher SHOP NOI, and new investments totaling $56.6 million with an 8.4% average initial yield. NHI also has $155.4 million in signed LOIs with an 8.4% average yield and is evaluating $270 million in potential investments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
-
Rhea-AI Summary

National Health Investors (NYSE:NHI) has announced the schedule for its second quarter 2024 earnings release and conference call. The company will release its Q2 2024 results after market close on Tuesday, August 6, 2024. A conference call to discuss the results is scheduled for Wednesday, August 7, 2024, at 11:00 a.m. Eastern Time.

Investors and analysts can participate in the interactive teleconference by calling (888) 506-0062 with the confirmation number 781474. Additionally, a live broadcast of the conference call will be available online at www.nhireit.com and https://www.webcaster4.com/Webcast/Page/633/50711. An online replay of the call will be accessible shortly after the live broadcast and will remain available for one year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
conferences earnings
-
News
Rhea-AI Summary

National Health Investors, Inc. (NHI) filed a supplemental proxy statement with the SEC detailing steps taken by the Board of Directors in response to stockholders' concerns. The Board plans to propose amending the Articles of Incorporation, search for a new director, and evaluate Board composition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
Rhea-AI Summary

National Health Investors, Inc. (NYSE:NHI) will pay a second quarter dividend of $0.90 per common share on August 2, 2024, to stockholders of record as of June 28, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
dividends earnings
-
News
Rhea-AI Summary

National Health Investors, Inc. (NYSE:NHI) has issued an investor update focusing on their real estate investments in senior housing and medical facilities. NHI's diverse portfolio includes various types of healthcare properties. For more details, visit their website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
none
-
News
Rhea-AI Summary

National Health Investors, Inc. (NYSE:NHI) announced its Q1 2024 results, showing net income per share of $0.71, NAREIT FFO per share of $1.10, and Normalized FFO per share of $1.12. The company updated its 2024 annual guidance and reported various financial figures. NHI's CEO highlighted deferral repayments, revenue growth, and raised guidance for the full year, emphasizing internal growth potential and financial strength.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
Rhea-AI Summary
National Health Investors, Inc. (NHI) announced the details for the release of its first-quarter results ending March 31, 2024. The company plans to issue its earnings release on May 6, 2024, followed by a conference call on May 7, 2024, to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
-
Rhea-AI Summary
National Health Investors, Inc. (NHI) declared a first quarter dividend of $0.90 per common share, payable on May 3, 2024, to stockholders of record by March 28, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags
dividends earnings
-
News
Rhea-AI Summary
National Health Investors, Inc. (NYSE:NHI) issues an investor update, showcasing their expertise in real estate investment trusts for senior housing and medical investments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags
none
Rhea-AI Summary
National Health Investors, Inc. (NYSE:NHI) reported strong financial results for the three and twelve months ended December 31, 2023, with significant increases in net income, NAREIT FFO, Normalized FFO, and Normalized FAD. The company issued its 2024 annual guidance range, showing positive growth expectations. Despite some challenges in interest expenses and losses, NHI's President and CEO, Eric Mendelsohn, expressed optimism for the future, emphasizing the company's financial stability and strategic advantage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags

FAQ

What is the current stock price of National Health Investors (NHI)?

The current stock price of National Health Investors (NHI) is $77.71 as of November 22, 2024.

What is the market cap of National Health Investors (NHI)?

The market cap of National Health Investors (NHI) is approximately 3.5B.

What types of properties are included in NHI's portfolio?

NHI's portfolio includes independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings, and specialty hospitals.

How does NHI generate its revenue?

NHI generates revenue primarily through rental income, mortgage and other notes receivable interest income, and resident fees and services.

What are the main segments of NHI's operations?

NHI operates through two main segments: Real Estate Investments and the Senior Housing Operating Portfolio (SHOP).

How has NHI performed financially in recent years?

NHI has maintained a strong financial profile with investment-grade credit ratings and has exceeded its 2023 guidance for NAREIT FFO, NFFO, and FAD, demonstrating resilience and growth.

What recent achievements has NHI made?

Recent achievements include successful deferral repayments, no unexpected rent concessions, substantial growth in the SHOP segment, and significant revenue growth.

What is the 2024 stock repurchase plan?

The 2024 stock repurchase plan totals $160 million, reflecting NHI’s commitment to returning value to shareholders.

What are NHI's plans for future investments?

NHI has a pipeline exceeding $300 million, with letters of intent submitted on more than $100 million at an average yield in excess of 8.0%, ensuring ongoing investment opportunities.

How does NHI maintain its financial stability?

NHI maintains financial stability through a robust balance sheet, significant liquidity from its revolving credit facility, and adherence to investment-grade credit ratings.

Who comprises NHI’s primary tenant base?

NHI's primary tenant base consists of senior housing operators and medical facility operators who lease or partner with NHI in various investment structures.

How can investors learn more about NHI?

Investors can learn more about NHI by visiting their official website at www.nhireit.com and reviewing their periodic reports and press releases.

National Health Investors

NYSE:NHI

NHI Rankings

NHI Stock Data

3.54B
43.30M
4.67%
68.05%
3.09%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States of America
MURFREESBORO